With the likelihood of a gene therapy and/or a stem cell treatment for retinal diseases to be approved for marketing within the next two to three years, it is time for the ophthalmic community – the suppliers, practitioners, patients and payers – to start thinking about how much these regenerative medicine treatments are likely to […]

Leer Más "What will Ophthalmic Gene Therapy and Stem Cell treatment cost and how will we and the healthcare system pay for it?"